Compare Schemes

Dezerv Corporate Surplus Management Strategy vs Polaris Human Plus Machine Converged Equity Strategy

Dezerv Corporate Surplus Management Strategy

Polaris Human Plus Machine Converged Equity Strategy

Add Scheme

Growth of ₹1 Crore

Dezerv Corporate Surplus Management Strategy

Polaris Human Plus Machine Converged Equity Strategy

1 Month

0.64%

9.44%

6 Months

3.85%

2.42%

1 Year

7.82%

1.29%

3 Years

—

5 Years

—

Since Inception

8.18%

23.68%

Fund Age

1 yr 11 mo

4 mo

AUM

₹268.89 Cr

₹2.91 Cr

Alpha – 1 Year

2.62%

0.33%

Alpha – 3 Years

—

Information Ratio – 3 Years

—

Volatility – 1 Year

—

Volatility – 3 Years

—

Beta – 1 Year

—

Beta – 3 Years

—

Sharpe Ratio – 1 Year

—

Sharpe Ratio – 3 Years

—

Worst Rolling Year

—

Value at Worst Rolling Year

—

Deepest Drawdown

—

Recovery Period

—

1-Year Rolling Windows Positive

—

Median Rolling Year

—

5-Year Rolling Windows Positive

—

Market-Cap Mix

—

M 5% · S 92%

Number of Stocks

—

Portfolio P/E

—

67.46

Top 5 Holdings

—

Shilpa Medicare Ltd · 11.42%

Cash & Cash Equivalent · 7.83%

Himadri Speciality Chemical Ltd · 7.42%

Sheela Foam Ltd · 6.84%

Rubicon Research Ltd · 6.78%

Top Sectors

—

Healthcare · 31.15%

Capital Goods · 20.12%

Chemicals · 13.97%

Fixed Fee

1.00% / yr

0.50% / yr

Performance Fee / Plan

10% of profit

Fixed Plan

Exit Load (Y1 / Y2 / Y3)

0% / 0% / 0%

Let's start a
conversation

Compare this PMS against 3,000+ others with our research desk
Build a long-term portfolio around your goals, not a one-off buy
Experts with decades of experience.

Private. Personal. No obligation.

We will only use these details to contact you about this enquiry. No spam.